PT98417A - Processo para a preparacao de composicoes farmaceuticas que compreendem um componente activo sujeito a degradacao - Google Patents

Processo para a preparacao de composicoes farmaceuticas que compreendem um componente activo sujeito a degradacao

Info

Publication number
PT98417A
PT98417A PT98417A PT9841791A PT98417A PT 98417 A PT98417 A PT 98417A PT 98417 A PT98417 A PT 98417A PT 9841791 A PT9841791 A PT 9841791A PT 98417 A PT98417 A PT 98417A
Authority
PT
Portugal
Prior art keywords
degradation
pharmaceutical compositions
active component
preparing pharmaceutical
component subject
Prior art date
Application number
PT98417A
Other languages
English (en)
Other versions
PT98417B (pt
Inventor
Bruce Allan Ross
Richard Victor Vivilecchia
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT98417A publication Critical patent/PT98417A/pt
Publication of PT98417B publication Critical patent/PT98417B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98417A 1990-07-25 1991-07-23 Processo para a preparacao de composicoes farmaceuticas que compreendem um componente activo sujeito a degradacao PT98417B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (2)

Publication Number Publication Date
PT98417A true PT98417A (pt) 1992-06-30
PT98417B PT98417B (pt) 1999-01-29

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98417A PT98417B (pt) 1990-07-25 1991-07-23 Processo para a preparacao de composicoes farmaceuticas que compreendem um componente activo sujeito a degradacao

Country Status (30)

Country Link
EP (1) EP0468929B1 (pt)
JP (1) JP2502849B2 (pt)
KR (1) KR100227156B1 (pt)
AT (1) AT400519B (pt)
AU (1) AU639354B2 (pt)
CA (1) CA2047802C (pt)
CH (1) CH683150A5 (pt)
CZ (1) CZ280184B6 (pt)
DE (1) DE4124409B4 (pt)
DK (1) DK0468929T3 (pt)
ES (1) ES2061218T3 (pt)
FI (1) FI98127C (pt)
GB (1) GB2246296B (pt)
HU (1) HU222489B1 (pt)
IE (1) IE66184B1 (pt)
IL (1) IL98934A (pt)
IT (1) IT1290797B1 (pt)
LU (1) LU87980A1 (pt)
MX (1) MX9100357A (pt)
MY (1) MY107183A (pt)
NO (1) NO912872D0 (pt)
NZ (1) NZ239078A (pt)
PL (1) PL167712B1 (pt)
PT (1) PT98417B (pt)
RU (1) RU2075310C1 (pt)
SA (1) SA92130106B1 (pt)
SK (1) SK278563B6 (pt)
TW (1) TW212757B (pt)
UA (1) UA26064A1 (pt)
ZA (1) ZA915861B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002564A1 (en) * 1994-07-13 1996-02-01 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
WO1999062560A1 (en) 1998-06-05 1999-12-09 Warner-Lambert Company Stabilization of compositions containing ace inhibitors using magnesium oxide
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) † 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
UA78542C2 (en) * 2002-01-15 2007-04-10 Actavis Group Hf Formulations of quinapril and other ace inhibitors
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN110662534A (zh) 2017-05-31 2020-01-07 勃林格殷格翰国际有限公司 包含(e)-4-(2-(氨基甲基)-3-氟烯丙基氧基)-n-叔丁基苯甲酰胺的药物组合物和药物剂型，其制备方法、治疗方法及用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
DK0468929T3 (da) 1994-12-27
MX9100357A (es) 1992-02-28
EP0468929B1 (en) 1994-09-28
HU222489B1 (hu) 2003-07-28
CS230991A3 (en) 1992-04-15
ZA915861B (en) 1993-03-31
PT98417B (pt) 1999-01-29
EP0468929A3 (en) 1992-02-19
HUT59819A (en) 1992-07-28
SA92130106B1 (ar) 2005-10-16
IL98934A0 (en) 1992-07-15
NO912872D0 (no) 1991-07-23
PL167712B1 (en) 1995-10-31
FI913554A0 (fi) 1991-07-24
DE4124409A1 (de) 1992-01-30
IT1290797B1 (it) 1998-12-11
IL98934A (en) 1996-07-23
CH683150A5 (de) 1994-01-31
KR100227156B1 (ko) 1999-10-15
GB9115893D0 (en) 1991-09-04
JP2502849B2 (ja) 1996-05-29
AU8128691A (en) 1992-01-30
ATA147691A (de) 1995-06-15
UA26064A1 (uk) 1999-04-30
MY107183A (en) 1995-09-30
IE66184B1 (en) 1995-12-13
CA2047802C (en) 2003-05-06
IE912608A1 (en) 1992-01-29
FI913554L (fi) 1992-01-26
ITRM910554A0 (it) 1991-07-23
JPH04253923A (ja) 1992-09-09
LU87980A1 (fr) 1993-02-15
FI98127B (fi) 1997-01-15
ES2061218T3 (es) 1994-12-01
FI98127C (fi) 1997-04-25
EP0468929A2 (en) 1992-01-29
CZ280184B6 (cs) 1995-11-15
ITRM910554A1 (it) 1993-01-23
TW212757B (pt) 1993-09-11
AU639354B2 (en) 1993-07-22
NZ239078A (en) 1993-10-26
SK278563B6 (en) 1997-10-08
AT400519B (de) 1996-01-25
KR920002146A (ko) 1992-02-28
DE4124409B4 (de) 2004-11-18
PL291219A1 (en) 1992-08-24
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
CA2047802A1 (en) 1992-01-26
RU2075310C1 (ru) 1997-03-20
HU9102385D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
BR9204011A (pt) Derivados 3-fenilpirazois,processo para suas preparacoes,composicoes funicidas e metodo de protecao de plantas
PT98497A (pt) Processo para a preparacao de particulas para a libertacao controlada de um ingrediente activo
BR9202653A (pt) Derivados de 3-aril-4-hidroxi-delta3-dihidrofuran ona e derivados de 3-aril-4-hidroxi-delta-dihidrotiofenona,processo para sua preparacao,composicoes inseticidas,processo para o combate de insetos,emprego e processo para a preparacao de composicoes
BR9100582A (pt) Derivados 3-arilpirrolidin-2,4-diona policiclicos,processo para sua preparacao,composicoes inseticidas,processo para combater insetos,aplicacao,processo para a preparacao de composicoes
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR1100979A (pt) Derivado de carboidrato, processo para preparar um derivado de carboidrato, composição farmacêutica de carboidrato e uso de derivado de carboidrato
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
BR9202522A (pt) Composto,formulacao farmaceutica e processo para preparar um composto
PT99671A (pt) Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem
BR9201657A (pt) Compostos derivados aromaticos aminados,processo para a preparacao dos mesmos e composicao farmaceutica
PT98417A (pt) Processo para a preparacao de composicoes farmaceuticas que compreendem um componente activo sujeito a degradacao
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
EP0863744A4 (en) LIPONIC ACID IN TOPICAL AGENTS
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
BR8803133A (pt) Compostos heterociclicos nitro-substituidos,processo para sua preparacao,composicoes inseticidas,processo para combater insetos,aplicacao e processo para a preparacao de composicoes
PT90224A (pt) Processo para a preparacao de composicoes sinergicas contendo imazalilo
BR9100297A (pt) Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes
PT93067A (pt) Processo para a preparacao de derivados de 2-hidroxiacidos alifaticos e de eteres de 1-benzil-3-hidroximetilindazol, e de composicoes farmaceuticas que os contem
BR9203798A (pt) Formulacao de liberacao prolongada,processo para preparar uma formulacao e processo para aumentar o crescimento em um animal
PT98842A (pt) Processo para a preparacao de derivados de fenilalanina e de fenetilamina n-substituidos com cicloalquilo e policicloalquilo, alfa-substituidos com arilo e heteroarilo e de composicoes farmaceuticas que os contem
BR9301273A (pt) Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido
PT98697A (pt) Processo para a preparacao de compostos macrociclicos e de composicoes farmaceuticas que os contem
PT98816A (pt) Processo para a preparacao de tienodiazepinas e de composicoes farmaceuticas que as contem
BR9002805A (pt) Derivados de 2-acilamino-4-halogeno-5-nitrotiazol,processo para a sua preparacao,sua aplicacao,composicao praguicida,processo para sua preparacao,processo para combater pragas,derivados de 4-halogeno-2-halogenocarbonilamino-5-nitrotiazol,processo para sua preparacao e sua aplicacao

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920225

FG3A Patent granted, date of granting

Effective date: 19981012

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20131014